Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2026-01-03 @ 7:26 AM
Study NCT ID:
NCT02293395
Status:
COMPLETED
Last Update Posted:
2017-12-26
First Post:
2014-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-13
First Submit QC Date:
None
Study First Post Date:
2014-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-10-11
Results First Submit QC Date:
None
Results First Post Date:
2017-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-30
Last Update Post Date:
2017-12-26
Last Update Post Date Type:
ACTUAL